Funds’ Partnership with eviCore healthcare Can Help Reduce Disparities
To help ensure your 1199SEIU patients receive the highest, most consistent standard of cancer care, the 1199SEIU Benefit Funds partnered with eviCore healthcare. Using established, evidence-based clinical pathways, eviCore supports clinicians in pursuing the most effective course of action for medical oncology treatment by reviewing pre-service elective radiation therapy and medical oncology services, as well as outpatient high-tech radiology and nuclear cardiology studies. This process helps maintain consistency in diagnoses and treatment methodology and reduce disparities in treatment and outcomes for 1199SEIU cancer patients. The partnership between the Benefit Funds and eviCore, as well as the prior authorization process, can limit patients’ exposure to potentially harmful radiation treatments and encourage a more holistic and patient-centered approach to healthcare delivery.